1
|
Le Goff E, Jondeau K, Venon MD, Greffe S, Ronez E, Ngo S, Kahn JE, Hanslik T. [Pseudohyperkalemia and thrombocytosis]. Rev Med Interne 2021; 42:438-441. [PMID: 33531232 DOI: 10.1016/j.revmed.2020.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2020] [Revised: 11/28/2020] [Accepted: 12/24/2020] [Indexed: 10/22/2022]
Abstract
INTRODUCTION Hyperkalemia is common in medicine and requires rapid management. Besides the easily evoked causes such as renal failure, adrenal insufficiency, cell lysis or iatrogenic causes, false or pseudo-hyperkalemia should not be forgotten. OBSERVATIONS Three patients (1 man, 2 women, aged 78, 84, 88) were managed for thrombocytosis (between 1306 and 2404 G/L) and non-symptomatic hyperkalemia (between 6.1 and 7.7mmol/L) are reported. Kalemia on blood collected in heparin tube was normal (4.4-4.6mmol/L). Therefore, no specific treatment for this pseudohyperkalemia was required. CONCLUSION The combination of thrombocytosis and non-symptomatic hyperkalemia should suggest the diagnosis of pseudohyperkalemia and should prompt for a control of kalemia on blood collected in heparin tube. The recognition of this diagnosis is important in order to avoid unnecessary and potentially deleterious treatment of hyperkalemia.
Collapse
Affiliation(s)
- E Le Goff
- Service de médecine interne, hôpital Ambroise-Paré, Assistance publique-Hôpitaux de Paris, 92100 Boulogne-Billancourt, France; UFR Simone Veil-Santé, université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France.
| | - K Jondeau
- Service de médecine interne, hôpital Ambroise-Paré, Assistance publique-Hôpitaux de Paris, 92100 Boulogne-Billancourt, France; UFR Simone Veil-Santé, université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France
| | - M-D Venon
- Service de médecine interne, hôpital Ambroise-Paré, Assistance publique-Hôpitaux de Paris, 92100 Boulogne-Billancourt, France; UFR Simone Veil-Santé, université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France
| | - S Greffe
- Service de médecine interne, hôpital Ambroise-Paré, Assistance publique-Hôpitaux de Paris, 92100 Boulogne-Billancourt, France; UFR Simone Veil-Santé, université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France
| | - E Ronez
- Service de médecine interne, hôpital Ambroise-Paré, Assistance publique-Hôpitaux de Paris, 92100 Boulogne-Billancourt, France; UFR Simone Veil-Santé, université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France
| | - S Ngo
- Service de médecine interne, hôpital Ambroise-Paré, Assistance publique-Hôpitaux de Paris, 92100 Boulogne-Billancourt, France; UFR Simone Veil-Santé, université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France
| | - J-E Kahn
- Service de médecine interne, hôpital Ambroise-Paré, Assistance publique-Hôpitaux de Paris, 92100 Boulogne-Billancourt, France; UFR Simone Veil-Santé, université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France
| | - T Hanslik
- Service de médecine interne, hôpital Ambroise-Paré, Assistance publique-Hôpitaux de Paris, 92100 Boulogne-Billancourt, France; UFR Simone Veil-Santé, université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France
| |
Collapse
|
2
|
Capron C, Jondeau K, Casetti L, Jalbert V, Costa C, Verhoeyen E, Massé JM, Coppo P, Béné MC, Bourdoncle P, Cramer-Bordé E, Dusanter-Fourt I. Erratum: Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727. Cell Death Dis 2015. [PMCID: PMC4669783 DOI: 10.1038/cddis.2014.596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
3
|
Capron C, Jondeau K, Casetti L, Jalbert V, Costa C, Verhoeyen E, Verhoyen E, Massé JM, Coppo P, Béné MC, Bourdoncle P, Cramer-Bordé E, Dusanter-Fourt I. Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727. Cell Death Dis 2014; 5:e1451. [PMID: 25299776 PMCID: PMC4237234 DOI: 10.1038/cddis.2014.393] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2014] [Revised: 08/22/2014] [Accepted: 08/25/2014] [Indexed: 12/18/2022]
Abstract
Chronic lymphoid leukemia (CLL) is characterized by the accumulation of functionally defective
CD5-positive B lymphocytes. The clinical course of CLL is highly variable, ranging from a
long-lasting indolent disease to an unpredictable and rapidly progressing leukemia requiring
treatment. It is thus important to identify novel factors that reflect disease progression or
contribute to its assessment. Here, we report on a novel STAT3-mediated pathway that characterizes
CLL B cells-extended viability and oxidative stress control. We observed that leukemic but not
normal B cells from CLL patients exhibit constitutive activation of an atypical form of the STAT3
signaling factor, phosphorylated on serine 727 (Ser727) in the absence of detectable
canonical tyrosine 705 (Tyr705)-dependent activation in vivo. The
Ser727-phosphorylated STAT3 molecule (pSTAT3Ser727) is localized to the
mitochondria and associates with complex I of the respiratory chain. This pSer727
modification is further controlled by glutathione-dependent antioxidant pathway(s) that mediate
stromal protection of the leukemic B cells and regulate their viability. Importantly,
pSTAT3Ser727, but neither Tyr705-phosphorylated STAT3 nor total STAT3, levels correlate
with prolonged in vivo CLL B cells survival. Furthermore, STAT3 activity contributes to the
resistance to apoptosis of CLL, but not normal B cells, in vitro. These data reveal that
mitochondrial (Mt) pSTAT3Ser727 overactivity is part of the antioxidant defense pathway
of CLL B cells that regulates their viability. Mt pSTAT3Ser727 appears to be a newly
identified cell-protective signal involved in CLL cells survival. Targeting pSTAT3Ser727
could be a promising new therapeutic approach.
Collapse
Affiliation(s)
- C Capron
- 1] Institut Cochin, Inserm U1016, Paris, France [2] Service d'Hématologie-Immunologie, Hôpital Ambroise Paré, Boulogne-Billancourt, France [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France [4] CNRS UMR8104, Paris, France [5] Université de Versailles St Quentin en Yvelines, Guyancourt, France
| | - K Jondeau
- 1] Service d'Hématologie-Immunologie, Hôpital Ambroise Paré, Boulogne-Billancourt, France [2] Université de Versailles St Quentin en Yvelines, Guyancourt, France
| | - L Casetti
- 1] Institut Cochin, Inserm U1016, Paris, France [2] Université Paris Descartes, Sorbonne Paris Cité, Paris, France [3] CNRS UMR8104, Paris, France
| | - V Jalbert
- Service d'Hématologie-Immunologie, Hôpital Ambroise Paré, Boulogne-Billancourt, France
| | - C Costa
- Ecole Normale Supérieure de Lyon, Université de Lyon, UCB-Lyon1, Lyon, France
| | | | - E Verhoyen
- 1] Ecole Normale Supérieure de Lyon, Université de Lyon, UCB-Lyon1, Lyon, France [2] INSERM U1065, Lyon, France
| | - J M Massé
- 1] Institut Cochin, Inserm U1016, Paris, France [2] Université Paris Descartes, Sorbonne Paris Cité, Paris, France [3] CNRS UMR8104, Paris, France
| | - P Coppo
- Service d'Hématologie Clinique, Hôpital Saint Antoine and Université UPMC, Paris, France
| | - M C Béné
- Service d'Hématologie Biologique, Hôtel-Dieu-CHU, Nantes, France
| | - P Bourdoncle
- 1] Institut Cochin, Inserm U1016, Paris, France [2] Université Paris Descartes, Sorbonne Paris Cité, Paris, France [3] CNRS UMR8104, Paris, France
| | - E Cramer-Bordé
- 1] Institut Cochin, Inserm U1016, Paris, France [2] Service d'Hématologie-Immunologie, Hôpital Ambroise Paré, Boulogne-Billancourt, France [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France [4] CNRS UMR8104, Paris, France [5] Université de Versailles St Quentin en Yvelines, Guyancourt, France
| | - I Dusanter-Fourt
- 1] Institut Cochin, Inserm U1016, Paris, France [2] Université Paris Descartes, Sorbonne Paris Cité, Paris, France [3] CNRS UMR8104, Paris, France
| |
Collapse
|
4
|
Trad S, Paule R, Ponsoye M, Jondeau K, Hanslik T, Caraman PL. [Arthralgia and weight loss in an 84-year-old woman]. Rev Med Interne 2011; 33:54-6. [PMID: 21816520 DOI: 10.1016/j.revmed.2011.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2011] [Accepted: 06/16/2011] [Indexed: 11/18/2022]
Affiliation(s)
- S Trad
- Service de médecine interne, hôpital Ambroise-Paré, 92104 Boulogne-Billancourt cedex, France.
| | | | | | | | | | | |
Collapse
|
5
|
Lefrère F, Zohar S, Ghez D, Delarue R, Audat F, Suarez F, Hermine O, Damaj G, Maillard N, Ribeil JA, Azagury M, Misbahi R, Jondeau K, Cavazzana-Calvo M, Dal Cortivo L, Varet B. The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients. Bone Marrow Transplant 2006; 37:725-9. [PMID: 16518433 DOI: 10.1038/sj.bmt.1705308] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
A study was conducted to compare the efficiency and toxicity of two peripheral blood stem cell (PBSC) mobilization procedures for newly diagnosed patients with multiple myeloma. Patients from group 1 (n=51) were treated by high-dose cyclophosphamide (HD-CY) plus G-CSF (5 microg/kg/day), and the second group (n=31) by VAD regimen plus G-CSF administration (10 microg/kg/day). Successful mobilization, defined by a minimal count of 2.5 x 10(6) CD34(+) cells/kg collected, was achieved in 96 and 90% of patients in groups 1 and 2, respectively (P=0.15). The mean peripheral blood CD34(+) cells concentration and the mean CD34(+) cells/kg collected were higher in group 2 than in the group 1 (P=0.05). The mean number of leukaphereses necessary to collect a count of 2.5 x 10(6) CD34(+) cells/kg was reduced in group 2 compared to group 1. Adverse events, blood products consumption and time spent in the hospital were significantly greater after HD-CY. In conclusion, VAD plus a G-CSF dose of 10 microg/kg administration seems preferential to HD-CY plus a G-CSF dose of 5 microg/kg for PBSC collection because of equivalent or better efficiency in stem cell mobilization, strong favorable toxicity profile and reduced cost.
Collapse
Affiliation(s)
- F Lefrère
- Service de Biothérapies, Hôpital Necker, AP-HP, Paris, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Thaunat O, Alyanakian MA, Varnous S, Bors V, Damaj G, Rerolle JP, Jondeau K, Varet B, Gandjbakhch I, Buzyn A. Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis. Bone Marrow Transplant 2005; 35:419-20. [PMID: 15640825 DOI: 10.1038/sj.bmt.1704772] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
7
|
Genet P, Pulik M, Gallet B, Lionnet F, Jondeau K, Touahri T, Laribi K. Acute myocardial ischemia after high-dose therapy with BEAM regimen. Bone Marrow Transplant 2002; 30:253-4. [PMID: 12203142 DOI: 10.1038/sj.bmt.1703632] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2001] [Accepted: 04/21/2002] [Indexed: 11/09/2022]
Abstract
We describe a case of acute myocardial ischemia following carmustine treatment during the BEAM regimen. Despite this, full completion of the autologous peripheral stem-cell transplant was possible.
Collapse
Affiliation(s)
- P Genet
- Department of Haematology, Hôpital Victor Dupouy, Argenteuil, France
| | | | | | | | | | | | | |
Collapse
|
8
|
Bouscary D, Jondeau K, Viguié F, Zompi S, Fontenay-Roupie M, Quarre MC, Vassilief D, Dreyfus F, Casadevall N. Aplastic anemia responsive to cyclosporine complicating the evolution of polycythemia vera. Leuk Lymphoma 1999; 33:607-11. [PMID: 10342591 DOI: 10.3109/10428199909058468] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
We report here a very unusual patient with Polycythemia vera treated with Pipobroman who developed severe aplastic anemia following administration of the drug. Six months later, because of lack of response, cyclosporine therapy was given there was rapid and complete hematological recovery, highly suggestive of an immune-mediated mechanism, in this case.
Collapse
Affiliation(s)
- D Bouscary
- Service d'Hématologie, Hôpital Cochin, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Pulik M, Lionnet F, Genet P, Jary L, Jondeau K. [Acute myelocytic leukemia in immunodeficiency virus infection]. Ann Med Interne (Paris) 1998; 149:475-8. [PMID: 10021898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Abstract
B lineage-derived malignant proliferation is a well recognized complication of HIV infection. Acute myeloid leukemias have been reported but no complete review of these cases has been performed. The Medline database was reviewed for the years 1980-1997. Eighteen cases of AML have been reported. When previously known, HIV infection was present for 40 months. In 7 patients HIV infection and AML were diagnosed simultaneously. According to the FAB classification, 5 cases were M2, 8 M4, 5 M5. Extramedullary localizations (skin, testis, spleen) were noticed in 10 patients. Non-treated patients had a survival of 2.7 weeks versus 9.8 months in patients treated with chemotherapy. Pathophysiologic studies were performed in 3 cases: reverse transcriptase activity and p24 antigen were noted in tumoral cultured cells in 1 case; absence of viral particules in culture in another one; absence of cloned DNA provirus integration in blasts cells in a third patient. Based on the observed high rate of M4/M5 (72%) versus 19-36% expected in a non HIV-infected population, we postulate that the association of AML and HIV is not coincidental. The monocytotropism of HIV, the chronic cytokines-mediated activation of monocyte/macrophages, the immunodeficiency may explain this association.
Collapse
Affiliation(s)
- M Pulik
- Service d'Hématologie, Centre Hospitalier, Argenteuil, France
| | | | | | | | | |
Collapse
|
10
|
Pulik M, Genet P, Jary L, Lionnet F, Jondeau K. Acute myeloid leukemias, multiple myelomas, and chronic leukemias in the setting of HIV infection. AIDS Patient Care STDS 1998; 12:913-9. [PMID: 11362062 DOI: 10.1089/apc.1998.12.913] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
B-cell lineage-derived high-grade malignant lymphomas are a well-recognized complication of HIV infection. However, isolated cases of unusual hematologic malignancies such as acute myeloid leukemias (AML), multiple myeloma (MM) or plasmacytomas, and chronic leukemias have been reported. This review focuses on these uncommon malignancies supervening in the setting of HIV infection. Eighteen cases of AML have been reported. Extramedullary localizations are frequently noticed. Nontreated patients have a survival of 2.7 weeks, compared with 9.8 months for patients treated with chemotherapy; being HIV-positive is not a contraindication to the treatment of AML. Based on the observed 72% incidence of AML M4 and M5 in an HIV-infected population versus 19% to 36% expected in a non-HIV-infected population, we postulate that the association of AML and HIV is not coincidental. The monocytotropism of HIV, the chronic cytokine-mediated activation of monocytes/macrophages, and the immunodeficiency may explain this association. Twenty-two cases of MM or plasmacytomas have been described, most of them in young patients. Again, extramedullary plasma cell tumors are recorded in many patients. Physiopathologic studies suggest that MM may develop because of an antigen-driven response to the circulating viral antigens. A role for Epstein-Barr virus (EBV) in the pathogenesis, as previously described in high-grade non-Hodgkin's lymphomas, is suggested by the presence of EBV genomes in plasma cell tumors. Finally, a broad spectrum of chronic leukemias derived from B- or T-cell lymphocyte lineage has been reported. These associations seem coincidental.
Collapse
Affiliation(s)
- M Pulik
- Service d'Hématologie, Centre Hospitalier d'Argenteuil, France
| | | | | | | | | |
Collapse
|
11
|
Jondeau K, Job-Deslandre C, Bouscary D, Khanlou N, Menkes CJ, Dreyfus F. Remission of nonerosive polyarthritis associated with Sjögren's syndrome after autologous hematopoietic stem cell transplantation for lymphoma. J Rheumatol 1997; 24:2466-8. [PMID: 9415659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
We describe a 50-year-old woman with seropositive rheumatoid arthritis and Sjögren's syndrome who underwent autologous blood stem cell transplantation after relapse of associated non-Hodgkin's lymphoma. This resulted in complete remission not only of the lymphoma, but also the arthritis.
Collapse
Affiliation(s)
- K Jondeau
- Service d'hématologie, Hôpital Cochin, Paris, France
| | | | | | | | | | | |
Collapse
|
12
|
Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J, Picard F, Dreyfus F, Fontenay-Roupie M. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia 1997; 11:839-45. [PMID: 9177438 DOI: 10.1038/sj.leu.2400654] [Citation(s) in RCA: 132] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Apoptosis of hematopoietic progenitor cells is increased in myelodysplastic syndromes (MDS). We have studied Fas (CD95/Apo-1) antigen expression in 27 MDS patients (RARS 4, RA 3, RAEB 13; RAEB-t 3, CMML 4) and three AML secondary to MDS. We found that the Fas antigen was not expressed on normal bone marrow (BM) CD34+, CD14+, or glycophorin+ cells, and only slightly on CD33+ cells. Patients with MDS had upregulation of Fas expression on total bone marrow nuclear cells (BMMC) (t-test, P = 0.04), CD34+ (P = 0.013), CD33+ (P = 0.04), and glycophorin+ (P = 0.032) BM cells compared to controls. Fas expression did not correlate to the FAB subtype, the Bournemouth score, or to peripheral cytopenias. However, Fas expression intensity on CD34+ cells negatively correlated to the BM blasts number (Spearman, P = 0.01) suggesting that leukemic blasts cells lose Fas antigen expression with progression of myelodysplasia. Using both proliferation assays in liquid cultures and clonogenic progenitor assays in the presence of an agonist anti-Fas MoAb (CH11), we showed that the Fas protein was functional in some patients. Dose-dependent inhibition of DNA synthesis was observed in three out of seven patients studied. CFU-GM and BFU-E colonies suppression in some patients suggested that Fas can induce apoptosis in myeloid and erythroid BM progenitors of MDS patients. The TUNEL technique on BM smears gave a mean of 12.6% +/- 2.5 of bone marrow apoptotic cells in five controls. Patients with MDS had increased bone marrow apoptosis (mean 39% +/- 5.7, t-test, P = 0.012). Four out of 15 (26%) patients studied with a sensitive radiolabeled DNA ladder technique had typical DNA ladders indicative of advanced stages of apoptosis. Massive BM suicide was observed in patients with RA (2/2) and RAEB (8/11), whereas apoptosis rates were normal or low in patients with RAEB-t (3/3) or secondary AMLs (3/3). Moreover, high rates of apoptosis correlated to low Bournemouth score (Spearman, P = 0.01). No statistical correlation could be found between Fas expression and apoptosis rates. Our results confirm the importance of programmed cell death in MDS. The Fas antigen is clearly upregulated on BM cells, but its role in the pathophysiology of apoptosis in myelodysplasia is still unclear, indicating that many factors positively or negatively interfere with the Fas-mediated pathway of apoptosis in vivo and in vitro.
Collapse
MESH Headings
- Adult
- Aged
- Aged, 80 and over
- Anemia, Refractory/classification
- Anemia, Refractory/immunology
- Anemia, Refractory/pathology
- Anemia, Refractory, with Excess of Blasts/classification
- Anemia, Refractory, with Excess of Blasts/immunology
- Anemia, Refractory, with Excess of Blasts/pathology
- Antigens, CD/analysis
- Antigens, CD/biosynthesis
- Apoptosis
- Bone Marrow/immunology
- Bone Marrow/pathology
- Bone Marrow Cells
- Cells, Cultured
- Colony-Forming Units Assay
- DNA/analysis
- DNA Fragmentation
- Female
- Hematopoietic Stem Cells/cytology
- Hematopoietic Stem Cells/immunology
- Hematopoietic Stem Cells/pathology
- Humans
- Karyotyping
- Leukemia, Myeloid/classification
- Leukemia, Myeloid/immunology
- Leukemia, Myeloid/pathology
- Male
- Middle Aged
- Myelodysplastic Syndromes/immunology
- Myelodysplastic Syndromes/pathology
- Reference Values
- Sensitivity and Specificity
- fas Receptor/analysis
- fas Receptor/biosynthesis
Collapse
Affiliation(s)
- D Bouscary
- Laboratoire d'Hematologie, Inserm U363, ICGM, Hôpital Chochin, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Jondeau K, Bouscary D, Viguié F, Picard F, Melle J, Lopez I, Fontenay-Roupie M, Dreyfus F. Thrombocytemia and abnormal megakaryopoiesis associated with abnormality of chromosome 1p34 in myelodysplastic syndromes. Leukemia 1996; 10:1692-5. [PMID: 8892668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases characterized by a cytopenia related to abnormal proliferation and differentiation of marrow precursor cells. Some subtypes of MDS are associated with thrombocytemia or abnormal megakaryopoiesis and certain specific karyotypic abnormalities. We report on four cases of MDS with normal or elevated blood platelet count and a recurring abnormality in chromosome 1p34. The gene involved appears to be different from c-mpl and TPO.
Collapse
Affiliation(s)
- K Jondeau
- Service d'hématologie, Hôpital Cochin, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|